LOS ANGELES – Financier Carl Icahn (search) on Friday offered to buy the shares of generic drugmaker Mylan Laboratories (MYL) that he does not already own for $4.9 billion, or $20 a share, according ...

PITTSBURGH – Generic drug maker Mylan Laboratories Inc. (MYL) is buying branded drug maker King Pharmaceuticals Inc. (KG) for about $4 billion in stock, company officials said Monday. Mylan has ...

Has Mylan Laboratories been stichting it to shareholders? This is what several Mylan shareholders claim in a lawsuit in which they argue a complicated maneuver the drug maker pursued to thwart hostile ...

You can add Mylan Laboratories to the list of drug makers boosting prices by big amounts. Over the past six months, the company, which is one of the world’s largest purveyors of generic medicines, ...

Mylan Labs Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 PITTSBURGH, Sept. 17 -- Mylan Laboratories Inc. (NYSE:MYL) ("Mylan") announced ...

Mylan Laboratories Inc. (MYL) Q1 2010 Earnings Call April 29, 2010 10:00 AM ETExecutivesDan Crookshank - VP, Global IRRobert Coury - Chairman & ...

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

PITTSBURGH, March 26 -- Mylan Inc. today announced its plans to purchase the remaining interest in Matrix Laboratories Limited from minority shareholders pursuant to a voluntary delisting offer. Mylan ...